• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AIZU OLYMPUS CO., LTD. EVIS EXERA III DUODENOVIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AIZU OLYMPUS CO., LTD. EVIS EXERA III DUODENOVIDEOSCOPE Back to Search Results
Model Number TJF-Q190V
Medical Device Problem Code Contamination (1120)
Health Effect - Clinical Codes Encephalopathy (1833); Sepsis (2067); Drug Resistant Bacterial Infection (4553)
Date of Event 05/07/2024
Type of Reportable Event Death
Event or Problem Description
It was reported that there were four (4) potential patients directly impacted by one suspected medical device.The patients underwent procedures involving the same individual suspected medical device between (b)(6) 2024.The patient referenced in this report was admitted to the hospital on (b)(6) 2024 for an endoscopic retrograde cholangiopancreatography (ercp) procedure with suspected medical device for removal of a stent previously placed in (b)(6) 2023.This patient had a past medical history of untreated stage iv lung cancer, pancreatic adenocarcinoma, and gero and was on palliative cares at an assisted living facility for multiple malignancies.The procedure was unable to replace stents after 2 hours of attempts to advance the duodenoscope.The patient was discharged the same day.The patient had an informational visit with hospice on (b)(6) 2024 with plans to transition to home hospice.The patient was then admitted on (b)(6) 2024 for worsening abdominal pain and underwent lnterventional radiology (ir) cholangiography and permanent stenting of a malignant stricture of the common bile duct on (b)(6) 2024.The patient had improving abdominal pain and was discharged on (b)(6) 2024.On (b)(6) 2024, the patient was admitted for acute metabolic encephalopathy and septic shock.The patient had been set to admit to hospice at an assisted living facility on (b)(6) 2024, but plans changed due to her returning to the hospital.Blood culture on admission was positive for carbapenamase-producing carbapenem resistant e.Coli (cp-cre) and klebsiella pneumoniae.The family approved no escalation of cares beyond intravenous antibiotics and fluids.The patient passed away on (b)(6) 2024.On (b)(6) 2024, ercp procedure involving suspected medical device was identified as possible link between multiple cp-cre infections.On august 21, 2024, suspected medical device was examined by borescope during facility investigation.Borescope revealed a small tear within the inner sheath of the device.It is unknown when the tear appeared on the scope, what caused it, and whether it was present for ercp procedures involving affected patients.The customer further reported that the death was potentially caused by this subject device; however, the customer was not sure if this device was the main cause of the death.The device had an inner sheath tear which the customer was not aware of, and they used the scope on several patients.The customer further stated that the device might have caused a cross contamination between patients.Reportedly, the device has been in quarantine in a secure location.The customer confirmed that the device passed the leak test prior to procedures being done.This report is related to the following linked patient identifiers: patient 1 (b)(6), patient 2 (b)(6), patient 3 (b)(6), patient 4 (b)(6).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS EXERA III DUODENOVIDEOSCOPE
Common Device Name
DUODENOVIDEOSCOPE
Manufacturer (Section D)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima 965-8 520
JA  965-8520
MDR Report Key20345297
Report Number2429304-2024-0000420
Device Sequence Number7994711
Product Code FDT
UDI-Device Identifier04953170405563
UDI-Public04953170405563
Combination Product (Y/N)N
Initial Reporter StateWI
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Importer
Initial Reporter Occupation Risk Manager
Type of Report Initial
Report Date (Section B) 10/01/2024
Report Date (Section F) 09/05/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberTJF-Q190V
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? Yes
Distributor Facility Aware Date09/05/2024
Event Location Hospital
Date Report to Manufacturer09/05/2024
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date10/01/2024
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ALLIANCE II 60ML SYRINGE/GUAGE ASSEMBLY; CRE FIXED WIRE ESOPHAGEAL BALLOON DILATION GATH 6F; CRE PRO WG 18-19-20MM X 240CM; HYDRA JAGWIRE ST 260 STRAIGHT TIP 0.032IN; RESCUE RAT TOOTH/ALLIGATOR GRASP FORCEP 8X230MM; RX ACCESSORY RAPID REFILL CONT LNJ SYSTEM; SENSATION SHORT THROW SNARE MED OVAL FLEXIBLE 27MM
Outcome Attributed to Adverse Event Hospitalization; Death; Required Intervention;
Patient Age84 YR
Patient SexFemale
Patient Weight65 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-